Elsevier Launches New "Trials from Resource-Limited Settings" section within Current Therapeutic Research: Clinical and Experimental

Bridgewater, NJ, November 6, 2006 – Elsevier, the publishers of Current Therapeutic Research: Clinical and Experimental, a peer-reviewed, rapid publication of original medical and pharmaceutical reports serving an international audience of scientists and clinicians, announces a new section within the journal titled, “Trials from Resource-Limited Settings”.

Much of the research published today fails to address the needs of the areas hardest hit by epidemics such as HIV. For example, while more than two thirds of the HIV-infected population lives in Africa, only 0.2% of research published in the top 50 biomedical journals comes from that continent. Language and publication bias are pervasive across all medical disciplines.

However, with “Trials from Resource-Limited Settings,” CTR now makes the inclusion of articles from resource-limited settings a key priority. It is hoped that this new addition will have an impact on therapeutic research efforts far beyond resource-limited settings. The publishers of CTR expect that this direction of focus will build on the inherent strengths of the journal while contributing in a significant way to the medical literature.

CTR will continue its commitment of working with authors to refine manuscripts and ensure that well-designed studies are published. As always, the publisher and medical editors will not only collaborate with the authors to standardize formatting and clarify study design and methods but also provide significant assistance to authors for whom English is a second language.

About Excerpta Medica
Excerpta Medica, an Elsevier business, is a global communications company that services global health care clients in the areas of medical education, medical communications, and publication planning. Excerpta Medica brings an experienced team of professionals from pharmaceuticals, health care, and medical publishing to deliver scientific and creative solutions. Excerpta Medica has offices in the US (Bridgewater, NJ) and The Netherlands (Amsterdam).

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases and online reference works.

Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier’s ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Note to Authors and Editors
CTR will begin accepting manuscript submissions immediately. To submit a manuscript, please visit www.CurrentTherapeuticRes.com or contact Jo-Ann E. West, Editorial Director, Publications Group at J.E.West@elsevier.com.

Contact Information

Jo-Ann E. West

Editorial Director

Elsevier

Contact via E-mail